Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer
| Autor: | Perets, R., Bar, J., Rasco, D.W., Ahn, M.-J., Yoh, K., Kim, D.-W., Nagrial, A., Satouchi, M., Lee, D.H., Spigel, D.R., Kotasek, D., Gutierrez, M., Niu, J., Siddiqi, S., Li, X., Cyrus, J., Chackerian, A., Chain, A., Altura, R.A., Cho, B.C. |
|---|---|
| Zdroj: | In Annals of Oncology March 2021 32(3):395-403 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|